Synthesis of 2-{(5-phenyl-1,3,4-Oxadiazol-2-yl)sulfanyl}-N-substituted acetamides as potential antimicrobial and hemolytic agents. 2016

Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
Department of Chemistry, Government College University, Lahore, Pakistan.

A new series of N-substituted derivatives of 2-{(5-phenyl-1,3,4-Oxadiazol-2-yl)sulfanyl}acetamides was synthesized. The synthesis was carried out by converting benzoic acid (1) into ethyl benzoate (2), benzohydrazide (3) and then 5-pheny-1,3,4-Oxadiazol-2-thiol (4) step by st0ep. The target compounds 6a-p were synthesized by reaction of compound 4 with equimolar ratios of different N-alkyl/aryl substituted 2-bromoacetamide (5a-p) in the presence of DMF and sodium hydride (NaH). The spectral (EI-MS, IR, (1)H-NMR) characterization of all the synthesized compounds reveal their successful synthesis. The compounds were also screened for antimicrobial & hemolytic activity and most of them were found to be active against the selected microbial species at variable extent relative to reference standards. But 6h was the most active against the selected panel of microbes. This series showed less toxicity and may be considered for further biological screening and application trial except 6m, possessing higher cytotoxicity.

UI MeSH Term Description Entries
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
April 2008, Archiv der Pharmazie,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
September 2019, Bioorganic chemistry,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
September 1983, Archiv der Pharmazie,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
September 2014, Indian journal of pharmaceutical sciences,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
July 2012, European journal of medicinal chemistry,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
March 2023, Pharmaceuticals (Basel, Switzerland),
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
May 2023, Pharmaceuticals (Basel, Switzerland),
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
July 2008, Acta crystallographica. Section E, Structure reports online,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
December 2007, Acta crystallographica. Section E, Structure reports online,
Aziz-ur Rehman, and Muhammad Athar Abbasi, and Sabahat Zahra Siddiqui, and Irshad Ahmad, and Muhammad Shahid, and Zinayyera Subhani
January 2008, Acta poloniae pharmaceutica,
Copied contents to your clipboard!